The Therapeutic Goods Administration is experiencing system issues linked to global Microsoft outages. Some services may be disrupted and we may take longer to respond to email and phone contact during this time.
AusPAR: Elasomeran
Australian Public Assessment Report
Device/Product Name
Spikevax
Active ingredients
Elasomeran
AusPAR Date
Published
Sponsor
Submission Number
PM-2021-02994-1-2
Submission Type
New biological entity
Decision
Approved for provisional registration